Caspase-8: a key role in the pathogenesis of diabetic embryopathy

Area of Science:

• Developmental biology
• Cellular and molecular biology
• Reproductive biology

Background:

• Maternal diabetes is a known risk factor for embryonic neural tube defects.
• Increased apoptosis (programmed cell death) in the neuroepithelium contributes to these defects.
• The specific molecular regulators of this process remain unclear.

Purpose of the Study:

• To investigate the role of caspase-8, an initiator caspase, in hyperglycemia-induced embryonic malformations.
• To elucidate the mechanism by which caspase-8 influences apoptosis in the developing neural tube.

Main Methods:

• Utilized a mouse embryo model to study the effects of maternal hyperglycemia.
• Assessed caspase-8 expression and activity in response to high glucose conditions.
• Examined the impact of caspase-8 inhibition on embryonic malformations, apoptosis, and downstream caspase activation (Bid, caspase-9).

Main Results:

• Caspase-8 is expressed in the developing neural tube and its activity is increased by hyperglycemia.
• Hyperglycemia-induced caspase-8 activation leads to Bid cleavage and increased apoptosis.
• Inhibiting caspase-8 activity in diabetic embryos significantly reduced malformations and neuroepithelial apoptosis.
• Caspase-8 inhibition also attenuated hyperglycemia-induced Bid activation and caspase-9 cleavage.

Conclusions:

• Caspase-8 is a key regulator of apoptosis in diabetic embryopathy.
• The findings suggest caspase-8 controls hyperglycemia-induced neural tube defects via the Bid-mediated mitochondrial pathway.
• Targeting caspase-8 may offer a therapeutic strategy for preventing birth defects associated with maternal diabetes.